VEGFA and peritoneum cancer: In combination with carboplatin and gemcitabine, it is indicated for the treatment of adult patients with first recurrence of platinum-sensitive epithelial ovarian, fallopian tube or primary peritoneal cancer who have not received prior therapy with bevacizumab or other VEGF inhibitors or VEGFRs targeted agents.